How do you manage persistent hyperuricemia in a patient with CKD3 and type 2 diabetes who has had severe reactions to both allopurinol (SJS) and febuxostat (drug rash), but only a single prior gout flare?
Would you pursue alternative urate-lowering therapy versus observation? Do you consider SGLT2 inhibitors to provide clinically meaningful urate reduction in this setting?
1 Answer
Mednet MemberInvited Expert
Rheumatology · Ohio State Dodd Rehabilitation Hospital
Answered on
I would just recommend conservative management in this scenario.
Unclear if there is an overneed to initiate any uricosuric agents in this scenario, given just single gout flare.
If there was a history of uric acid stones, then would consider an alternative but that would be challenging, given canno...
Join for free or sign in to see the full answer